drugset
Drugs / Mulberry Twig (Ramulus Mori, Sangzhi) Alkaloid Tablet 50mg po tid
last change Dec 2023 re-read 9 days ago

Mulberry Twig (Ramulus Mori, Sangzhi) Alkaloid Tablet 50mg po tid

also known as Mulberry Twig (Ramulus Mori, Sangzhi) Alkaloid Tablet
Developed for
type 2 diabetes mellitus
Investigated by
Nanjing First Hospital, Nanjing Medical University

Trials 1

today NCT05856578 · Ph 4
2023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT05856578 Mar 2022 → May 2023 type 2 diabetes mellitus Nanjing First Hospital, Nanjing Medical University Unknown No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Mulberry Twig (Ramulus Mori, Sangzhi) Alkaloid Tablet 50mg po tid ClinicalTrials.gov intervention name — accepted as the source's own label NCT05856578 ↗
Known as Mulberry Twig (Ramulus Mori, Sangzhi) Alkaloid Tablet “Mulberry Twig (Ramulus Mori, Sangzhi) Alkaloid Tablet 50mg po tid” NCT05856578 ↗
Route Oral “Mulberry Twig (Ramulus Mori, Sangzhi) Alkaloid Tablet 50mg po tid” NCT05856578 ↗